We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $931M
1-Year Est. Return 41.63%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+41.63%
3 Year Est. Return
+181.18%
5 Year Est. Return
+113.34%
10 Year Est. Return
+1,823.73%
AUM
$4.93B
AUM Growth
-$733M
Cap. Flow
-$52.9M
Cap. Flow %
-1.07%
Top 10 Hldgs %
45.48%
Holding
165
New
19
Increased
18
Reduced
16
Closed
21

Top Buys

Rank Stock Value
1
OTLY
Oatly Group
OTLY
+$37.3M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$32.5M
3
TRML
Tourmaline Bio
TRML
+$31.6M
4
SAGE
Sage Therapeutics
SAGE
+$24.7M
5
VERV
Verve Therapeutics
VERV
+$20.8M

Top Sells

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$98.3M
2
INTC icon
Intel
INTC
+$47M
3
CCXI
ChemoCentryx, Inc.
CCXI
+$38.4M
4
AVGO icon
Broadcom
AVGO
+$34.8M
5
BEKE icon
KE Holdings
BEKE
+$34.2M

Sector Composition

Rank Sector Weight
1 Healthcare 75.69%
2 Consumer Discretionary 10.87%
3 Miscellaneous 10.83%
4 Consumer Staples 0.74%
5 Industrials 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPNG icon
151
Coupang
CPNG
$27.2B
– –
-400,000
Closed -$19.7M
GDS icon
152
GDS Holdings
GDS
$6.18B
– –
-100,000
Closed -$8.11M
INTC icon
153
Intel
INTC
$514B
– –
-800,000
Closed -$47M
IOVA icon
154
Iovance Biotherapeutics
IOVA
$4.19B
– –
-400,000
Closed -$12.7M
KWEB icon
155
CALL
KraneShares CSI China Internet ETF
KWEB
$4.73B
– –
-200,000
Closed -$15.3M
MANU icon
156
Manchester United
MANU
$3.46B
– –
-12,488
Closed -$197K
PTGX icon
157
Protagonist Therapeutics
PTGX
$9.56B
– –
-75,000
Closed -$1.94M
SHLS icon
158
Shoals Technologies Group
SHLS
$1.19B
– –
-100,000
Closed -$3.48M
SLB icon
159
CALL
SLB Ltd
SLB
$79.1B
– –
-1,000,000
Closed -$27.2M
TCOM icon
160
Trip.com Group
TCOM
$24.6B
– –
-250,000
Closed -$9.91M
TME icon
161
Tencent Music
TME
$13.2B
– –
-550,000
Closed -$11.3M
XBI icon
162
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.6B
– –
-500,000
Closed -$67.8M
XLE icon
163
CALL
State Street Energy Select Sector SPDR ETF
XLE
$42.4B
– –
-100,000
Closed -$2.45M
Z icon
164
Zillow
Z
$7.46B
– –
-100,000
Closed -$13M
CCXI
165
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-750,000
Closed -$38.4M
3 4 5 6
7

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $931M AUM 47.97% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $931M AUM 4.95% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
NS
Night Squared New York $930M AUM 56.46% 1-Year Est. Return
PA
Planning Alternatives Birmingham, Michigan $933M AUM 28.32% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $933M AUM 56.2% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $929M AUM 53.07% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Artal Group's Q2 2021 Portfolio in Review

As of Q2 2021, Artal Group held 165 positions worth $4.93B, down 13% from $5.66B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Artal Group's Q2 2021 filing shows 19 new, 18 increased, 16 reduced and 21 closed positions. Its largest new stake was Oatly Group: 75,000 shares worth $36.7M. The largest sale was BioNTech, an estimated $98.3M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, up from 70% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.

  • Artal Group's largest Q2 2021 buy was Oatly Group: 75,000 shares worth $36.7M.
  • Artal Group added most to Sage Therapeutics in Q2 2021, an estimated $24.7M increase.
  • Artal Group's biggest Q2 2021 reduction was TG Therapeutics, cutting an estimated $27.5M.
  • Artal Group fully exited BioNTech in Q2 2021, selling an estimated $98.3M.
  • Artal Group's ten largest holdings make up 45% of its $4.93B portfolio in Q2 2021.
  • Artal Group opened 19 new positions and closed 21 in Q2 2021.
  • Artal Group's portfolio value fell 13% quarter-over-quarter to $4.93B.

Based on Artal Group's 13F filing for Q2 2021, filed 13 Aug 2021.